A former HWL Ebsworth capital partner alleging he was unlawfully expelled and excluded from a planned float on the ASX has argued HWLE’s late managing partner, Juan Martinez, thought the firm could “hire and fire at will” without giving proper reasons.
A judge has railed against the parties in a class action against Sydney-based plastic surgeon Daniel Lanzer and four of his associates for “repeated failure to comply with court orders” in the two-year-old case.
Glencore-owned Viterra must pay indemnity costs to four Joe White employees it dragged into a 10-year feud with Cargill over the $420 million sale of the Joe White business, after a judge found its claims against them were “hopeless from the outset”.
Livestock drug company Zoetis has agreed to accept a $2.1 million payout to cover its costs in successfully defending a class action dubbed “totally off the planet” by a judge.
A disgruntled client who accused a Sydney-based law firm of running a “woefully prepared” case has lost his appeal of a judge’s rejection of his bid for a $225,000 personal costs order against the firm.
A class action against Virgin Australia has become a lawyers’ feast, with seven new firms entering the ring after a dozen insurers were joined to the action alleging the airline failed to disclose its true financial position in a $324 million capital raising prospectus.
A judge has directed a class action on behalf of 1,000 patients of Sydney-based plastic surgeon Daniel Lanzer and four of his associates to have another go at articulating claims that Lanzer’s clinic should be liable for allegedly ‘horrific’ complications.
A judge has allowed the applicants in a class action against a law firm extra time to file evidence after the death of the solicitor on record, despite protests from the firm, which is accused in the case of liability for the alleged fraud of a former employee.
A judge has criticised HWL Ebsworth’s discovery efforts and ordered the law firm to try again in the firm’s dispute with a former partner claiming the company cut him out of a proposed ASX float in 2020.
Pet and livestock drug company Zoetis, which successfully defended a class action over its horse vaccine Equivac, is pressing forward with its claim against the legal team that ran the unfunded case, seeking to recover $500,000 of its $3.8 million legal bill.